Alnylam Pharma (ALNY) Tops Q4 EPS by 32c
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $242.61 +6.12%
Financial Fact:
Comprehensive loss: -109.41M
Today's EPS Names:
JAGX, CLIR, ZTO, More
Financial Fact:
Comprehensive loss: -109.41M
Today's EPS Names:
JAGX, CLIR, ZTO, More
Join SI Premium – FREE
Alnylam Pharma (NASDAQ: ALNY) reported Q4 EPS of ($0.28), $0.32 better than the analyst estimate of ($0.60). Revenue for the quarter came in at $24.02 million versus the consensus estimate of $13.1 million.
For earnings history and earnings-related data on Alnylam Pharma (ALNY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Starts Alnylam Pharmaceuticals (ALNY) at Outperform
- Wolfspeed (WOLF) Misses Q4 EPS by 174c; Offers Guidance
- Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
